AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Analyst Ranking
Top 15%
#826 out of 5550 analysts
Average Return
+6.43%
Win Rate
45%78 out of 172
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Arrowhead Pharmaceuticals IncARWR | +433.80% | $16.42 | $87.65 | 2025-08-08 - 2026-08-07 | Buy |
Uniqure NvQURE | +263.97% | $7.16 | $26.06 | 2024-11-06 - 2025-11-05 | Buy |
Arrowhead Pharmaceuticals IncARWR | +233.09% | $18.89 | $62.92 | 2025-02-11 - 2026-02-10 | Buy |
Dyne Therapeutics IncDYN | +181.52% | $9.20 | $25.90 | 2025-07-29 - 2026-07-28 | Buy |
Ionis Pharmaceuticals IncIONS | +154.34% | $32.69 | $83.15 | 2025-02-20 - 2026-02-19 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals IncALNY | 32 | Buy | $280.00 | +77.22% | Maintains | 4 days ago |
Argenx SeARGX | 8 | Buy | $1,025.00 | +17.15% | Maintains | 14 days ago |
Amgen IncAMGN | 2 | Buy | $430.00 | -7.62% | Maintains | a month ago |
Caribou Biosciences IncCRBU | 6 | Hold | $1.00 | +127.27% | Downgrades | a month ago |
Uniqure NvQURE | 10 | Buy | $48.00 | +108.97% | Maintains | a month ago |
Solid Biosciences IncSLDB | 1 | Buy | $18.00 | +200.00% | Initiates Coverage On | 2 months ago |
Dyne Therapeutics IncDYN | 6 | Buy | $30.00 | +73.41% | Maintains | 2 months ago |
Arrowhead Pharmaceuticals IncARWR | 13 | Buy | $100.00 | +67.87% | Reiterates | 2 months ago |
Ascendis Pharma AASND | 7 | Buy | $290.00 | +16.48% | Maintains | 3 months ago |
Ionis Pharmaceuticals IncIONS | 13 | Buy | $85.00 | +106.11% | Maintains | 4 months ago |
Ultragenyx Pharmaceutical IncRARE | 4 | Buy | $40.00 | +145.40% | Maintains | 4 months ago |
Moderna IncMRNA | 21 | Hold | $45.00 | -79.62% | Maintains | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 14 | Hold | $62.00 | +7.94% | Maintains | 4 months ago |
Agios Pharmaceuticals IncAGIO | 2 | Hold | $32.00 | +6.84% | Maintains | 4 months ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $100.00 | +33.34% | Initiates Coverage On | 7 months ago |
Intellia Therapeutics IncNTLA | 8 | Hold | $15.00 | +28.64% | Maintains | 8 months ago |
Beam Therapeutics IncBEAM | 8 | Hold | $26.00 | +0.50% | Maintains | 8 months ago |
Wave Life Sciences IncWVE | 6 | Buy | $27.00 | +667.05% | Upgrades | a year ago |
Fulcrum Therapeutics IncFULC | 3 | Hold | $10.00 | +173.97% | Maintains | a year ago |
Korro Bio IncKRRO | 8 | Hold | $8.00 | -49.51% | Downgrades | a year ago |
Crispr Therapeutics AgCRSP | 14 | Hold | $50.00 | +0.02% | Maintains | a year ago |
Regenxbio IncRGNX | 10 | Buy | $19.00 | +165.36% | Maintains | a year ago |
Avidity Biosciences IncRNAM | 3 | Hold | $72.00 | N/A | Downgrades | a year ago |
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | N/A | Maintains | a year ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | N/A | Reiterates | a year ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | N/A | Maintains | a year ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | N/A | Maintains | 2 years ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | N/A | Maintains | 2 years ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | N/A | Maintains | 2 years ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | N/A | Maintains | 2 years ago |
Slb LimitedSLB | 1 | Buy | $57.00 | N/A | Reiterates | 2 years ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | N/A | Maintains | 2 years ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | N/A | Reiterates | 2 years ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 4 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 4 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 5 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.